This means you can reach a provider or support staff at any time with questions about side effect management , dosing timing , or concerns about your treatment progress
Abbreviations ADA: American Diabetes Association AE: Adverse event ASCVD: Atherosclerotic cardiovascular disease CI: Confidence interval CKD: Chronic kidney disease CVOT: Cardiovascular outcomes trial EASD: European Association for the Study of Diabetes eGFR: Estimated glomerular filtration rate GLP-1RA: Glucagon-like peptide-1 receptor agonist HbA1c: Hemoglobin A1c HF: Heart failure HHF: Hospitalization for heart failure HR: Hazard ratio MACE: Major adverse cardiovascular events OR: Odds ratio RCT: Randomized controlled trial RR: Relative risk SBP: Systolic blood pressure SGLT2i: Sodium-glucose cotransporter-2 inhibitor T2DM: Type 2 diabetes mellitus References Daz-Trastoy O, Villar-Taibo R, Sifontes-Dubn M, Mozo-Pealver H, Bernabeu-Morn I, Cabezas-Agrcola JM, et al
IGF-1 downregulated key elements such as transporters associated with antigen processing (TAPs), endoplasmic reticulum aminopeptidase-1 (ERAP-1), and Class I 2-microglobulin, without significantly altering Class I allele expression
J Am Vet Med Assoc (1997) 211:31821
This question concerns many patients considering this dual GIP/GLP-1 receptor agonist for type 2 diabetes or weight management
